Cytodyn Inc (CYDY)

[Saltz]

I have to believe it is BLA acceptance or approval. If it is acceptance rather than approval that would be a big deal. If it is just submission that’s bigger. All this obviously affects the urgency to raise $.

Agreed not the company I’d hoped for but a deal is better than no deal. One step closer to monetizing which is important in insuring this doesn’t leave us with empty pockets.

The next six months are critical. BLA submission, acceptance, and approval and advancement of mTNBC trials. It’s clear Nader is strapped in terms of cash and that is affecting enrollment. Incentivized to make BLA number one priority and that’s a good thing.

All in all more than I expected on this call. Now the reality of this deal will need to be digested to determine its value. For starters risk has been diminished. On the other hand we are still short $ in the short term.